Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Oncology·MeSH: Lung Diseases
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| tas6417 | CG Oncology, Inc. (CGON) |
Frequently asked questions
How many drugs are in development for Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation?
BioSniper tracks 1 drug in development for Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation across 1 company.
How many clinical trials target Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation?
There are 1 clinical trial targeting Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation tracked by BioSniper.
Deep-dive into Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis